<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">helmholtzeyeinstitute</journal-id><journal-title-group><journal-title xml:lang="ru">Российский офтальмологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Ophthalmological Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0076</issn><issn pub-type="epub">2587-5760</issn><publisher><publisher-name>Real time Publishers</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21516/2072-0076-2018-11-3-50-54</article-id><article-id custom-type="elpub" pub-id-type="custom">helmholtzeyeinstitute-170</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>В ПОМОЩЬ ПРАКТИЧЕСКОМУ ВРАЧУ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>FOR OPHTHALMOLOGY PRACTITIONERS</subject></subj-group></article-categories><title-group><article-title>ПОРАЖЕНИЕ ГЛАЗ ПРИ БОЛЕЗНИ ЛАНДУЗИ-ДЕЖЕРИНА (ОПИСАНИЕ СЛУЧАЕВ И АНАЛИЗ ЛИТЕРАТУРЫ)</article-title><trans-title-group xml:lang="en"><trans-title>EYE PATHOLOGIES IN FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY (CASE REPORT AND LITERARY ANALYSIS)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Денисова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Denisova</surname><given-names>E. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Катаргина</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Katargina</surname><given-names>L. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коголева</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kogoleva</surname><given-names>L. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Белова</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Belova</surname><given-names>M. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Осипова</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Osipova</surname><given-names>N. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Федосеева</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Fedoseeva</surname><given-names>E. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ "Московский НИИ глазных болезней им. Гельмгольца" Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Moscow Helmholtz Research Institute of Eye Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>03</day><month>10</month><year>2018</year></pub-date><volume>11</volume><issue>3</issue><fpage>50</fpage><lpage>54</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Денисова Е.В., Катаргина Л.А., Коголева Л.В., Белова М.В., Осипова Н.А., Федосеева Е.В., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Денисова Е.В., Катаргина Л.А., Коголева Л.В., Белова М.В., Осипова Н.А., Федосеева Е.В.</copyright-holder><copyright-holder xml:lang="en">Denisova E.V., Katargina L.A., Kogoleva L.V., Belova M.V., Osipova N.A., Fedoseeva E.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://roj.igb.ru/jour/article/view/170">https://roj.igb.ru/jour/article/view/170</self-uri><abstract><p>Помимо классической болезни Коатса, характеризующейся образованием телеангиоэктазий и микроаневризм сосудов сетчатки, окруженных желтоватым интра- и субретинальным экссудатом, и развивающейся у соматически здоровых детей, коатсоподобные изменения сетчатки могут наблюдаться при ряде системных заболеваний, а также осложнять течение другой глазной патологии. Одним из заболеваний, протекающих с коатсоподобной экссудативной васкулопатией, является плече-лопаточно-лицевая миопатия или болезнь Ландузи-Дежерина. Системными проявлениями данной патологии являются характерный миодистрофический процесс, затрагивающий, как правило, мышцы лица, рук и дистальные мышцы ног, а также нейросенсорная тугоухость, дыхательная недостаточность, сердечная аритмия, при инфантильной форме - задержка умственного развития и эписиндром. Приведено описание двух клинических случаев детей с болезнью Ландузи-Дежерина, представлены результаты лечения, обсуждена важность системного подхода при обследовании пациентов с коатсоподобными изменениями глазного дна. Для цитирования: Денисова Е.В., Катаргина Л.А., Коголева Л.В., Белова М.В., Осипова Н.А., Федосеева Е.В. Поражение глаз при болезни Ландузи-Дежерина (описание случаев и анализ литературы). Российский офтальмологический журнал. 2018; 11(2):50-54.</p></abstract><trans-abstract xml:lang="en"><p>In addition to the classic Coats’ disease characterized by retinal vascular telangiectasias and aneurysmal dilatations surrounded by yellowish intra- and subretinal exudates and developing in somatically healthy children, Coats’-like retinal changes can occur in a number of systemic diseases and complicate the course of other eye pathologies. One of the diseases that occur with Coats’-like exudative vasculopathy is facioscapulohumeral muscular dystrophy, or Landouzy - Dejerine disease. Systemic manifestations of this pathology are the myodystrophic process, which usually affects muscles of the face and arms and distal muscles of the legs, as well as sensorineural hearing loss, respiratory failure, cardiac arrhythmia, in the infantile form - mental retardation and episyndrome. The paper describes two clinical cases involving children with facioscapulohumeral muscular dystrophy, presents the results of treatment, and discusses the importance of a systematic approach in examining patients with Coats’-like retinal changes. For citation: Denisova E.V., Katargina L.A., Kogoleva L.V., Belova M.V., Osipova N.A., Fedoseeva E.V. Eye pathologies in facioscapulohumeral muscular dystrophy (case report and literary analysis). Russian ophthalmological journal. 2018; 11 (3): 50-4 (In Russian). doi: 10.21516/2072-0076-2018-11-3-50-54</p></trans-abstract><kwd-group xml:lang="ru"><kwd>коатсоподобная ретинопатия</kwd><kwd>плече-лопаточно-лицевая миопатия</kwd><kwd>болезнь Ландузи-Дежерина</kwd><kwd>Coats’-like retinopathy</kwd><kwd>facioscapulohumeral muscular dystrophy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Мосин И. М. Болезнь Коатса. В кн. Шамшинова А.М., ред. Наследственные и врожденные заболевания сетчатки и зрительного нерва. Москва: Медицина; 2001: 297-324.</mixed-citation><mixed-citation xml:lang="en">Мосин И. М. Болезнь Коатса. В кн. Шамшинова А.М., ред. Наследственные и врожденные заболевания сетчатки и зрительного нерва. Москва: Медицина; 2001: 297-324.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Recchia F.M. Coats Disease. In: Harnett M.E., ed. Pediatric Retina. 2nd ed. Philadelphia: Lippincott Williams Wilkins; 2013: 616-25.</mixed-citation><mixed-citation xml:lang="en">Recchia F.M. Coats Disease. In: Harnett M.E., ed. Pediatric Retina. 2nd ed. Philadelphia: Lippincott Williams Wilkins; 2013: 616-25.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Tawil R., Van Der Maarel S. M. Facioscapulohumeral muscular dystrophy. Muscle Nerve. 2006; 34(1): 1-15.</mixed-citation><mixed-citation xml:lang="en">Tawil R., Van Der Maarel S. M. Facioscapulohumeral muscular dystrophy. Muscle Nerve. 2006; 34(1): 1-15.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Tawil R., Kissel J. T., Heatwole C., et al. Evidence-based guideline summary: Evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy. Neurology. 2015; 85(4): 357-64.</mixed-citation><mixed-citation xml:lang="en">Tawil R., Kissel J. T., Heatwole C., et al. Evidence-based guideline summary: Evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy. Neurology. 2015; 85(4): 357-64.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Bindoff L. A., Mjellem N., Sommerfelt K., et al. Severe fascioscapulohumeral muscular dystrophy presenting with Coats' disease and mental retardation. Neuromuscul. Disord. 2006; 16(9-10): 559-63.</mixed-citation><mixed-citation xml:lang="en">Bindoff L. A., Mjellem N., Sommerfelt K., et al. Severe fascioscapulohumeral muscular dystrophy presenting with Coats' disease and mental retardation. Neuromuscul. Disord. 2006; 16(9-10): 559-63.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Fitzsimons R. B., Gurwin E. B., Bird A. C. Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. A general association with genetic and therapeutic implications. Brain. 1987; 110 (Pt 3): 631-48.</mixed-citation><mixed-citation xml:lang="en">Fitzsimons R. B., Gurwin E. B., Bird A. C. Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. A general association with genetic and therapeutic implications. Brain. 1987; 110 (Pt 3): 631-48.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Gurwin E.B., Fitzsimons R.B., Sehmi K.S., Bird A.C. Retinal telangiectasis in facioscapulohumeral muscular dystrophy with deafness. Arch. Ophthalmol. 1985; 103(11): 1695-700.</mixed-citation><mixed-citation xml:lang="en">Gurwin E.B., Fitzsimons R.B., Sehmi K.S., Bird A.C. Retinal telangiectasis in facioscapulohumeral muscular dystrophy with deafness. Arch. Ophthalmol. 1985; 103(11): 1695-700.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Pauleikhoff D., Bornfeld N., Bird A.C., Wessing A. Severe visual loss associated with retinal telangiectasis and facioscapulohumeral muscular dystrophy. Graefes Arch. Clin. Exp. Ophthalmol. 1992; 230(4): 362-5.</mixed-citation><mixed-citation xml:lang="en">Pauleikhoff D., Bornfeld N., Bird A.C., Wessing A. Severe visual loss associated with retinal telangiectasis and facioscapulohumeral muscular dystrophy. Graefes Arch. Clin. Exp. Ophthalmol. 1992; 230(4): 362-5.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Gaillard M. C., Mataftsi A., Balmer A., Houghton S., Munier F. L. Ranibizumab in the management of advanced Coats disease Stages 3B and 4: long-term outcomes. Retina. 2014; 34(11): 2275-81. doi: 10.1097/IAE.0000000000000248</mixed-citation><mixed-citation xml:lang="en">Gaillard M. C., Mataftsi A., Balmer A., Houghton S., Munier F. L. Ranibizumab in the management of advanced Coats disease Stages 3B and 4: long-term outcomes. Retina. 2014; 34(11): 2275-81. doi: 10.1097/IAE.0000000000000248</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Henry C. R., Sisk R. A., Tzu J. H., et al. Long-term follow-up of intravitreal bevacizumab for the treatment of pediatric retinal and choroidal diseases. J. AAPOS. 2015; 19(6): 541-8. doi: 10.1016/j.jaapos.2015.09.006</mixed-citation><mixed-citation xml:lang="en">Henry C. R., Sisk R. A., Tzu J. H., et al. Long-term follow-up of intravitreal bevacizumab for the treatment of pediatric retinal and choroidal diseases. J. AAPOS. 2015; 19(6): 541-8. doi: 10.1016/j.jaapos.2015.09.006</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kaul S., Uparkar M., Mody K., et al. Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of Сoats' disease in children. Indian J. Ophthalmol. 2010; 58(1): 76-8. doi: 10.4103/0301-4738.58480</mixed-citation><mixed-citation xml:lang="en">Kaul S., Uparkar M., Mody K., et al. Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of Сoats' disease in children. Indian J. Ophthalmol. 2010; 58(1): 76-8. doi: 10.4103/0301-4738.58480</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Lin C. J., Hwang J.F., Chen Y. T., Chen S. N. The effect of intravitreal bevacizumab in the treatment of Coats disease in children. Retina. 2010; 30(4): 617-22. doi: 10.1097/IAE.0b013e3181c2e0b7</mixed-citation><mixed-citation xml:lang="en">Lin C. J., Hwang J.F., Chen Y. T., Chen S. N. The effect of intravitreal bevacizumab in the treatment of Coats disease in children. Retina. 2010; 30(4): 617-22. doi: 10.1097/IAE.0b013e3181c2e0b7</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ramasubramanian A., Shields C. L. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction. Br. J. Ophthalmol. 2012; 96(3): 356-9. doi: 10.1136/bjophthalmol-2011-300141</mixed-citation><mixed-citation xml:lang="en">Ramasubramanian A., Shields C. L. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction. Br. J. Ophthalmol. 2012; 96(3): 356-9. doi: 10.1136/bjophthalmol-2011-300141</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ray R., Barañano D. E., Hubbard G. B. Treatment of Coats' disease with intravitreal bevacizumab. Br. J. Ophthalmol. 2013; 97(3): 272-7. doi: 10.1136/bjophthalmol-2012-302250</mixed-citation><mixed-citation xml:lang="en">Ray R., Barañano D. E., Hubbard G. B. Treatment of Coats' disease with intravitreal bevacizumab. Br. J. Ophthalmol. 2013; 97(3): 272-7. doi: 10.1136/bjophthalmol-2012-302250</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Villegas V. M., Gold A. S., Berrocal A. M., Murray T. G. Advanced Coats’ disease treated with intravitreal bevacizumab combined with laser vascular ablation. Clin. Ophthalmol. 2014; 16(8): 973-6. doi: 10.2147/OPTH.S62816</mixed-citation><mixed-citation xml:lang="en">Villegas V. M., Gold A. S., Berrocal A. M., Murray T. G. Advanced Coats’ disease treated with intravitreal bevacizumab combined with laser vascular ablation. Clin. Ophthalmol. 2014; 16(8): 973-6. doi: 10.2147/OPTH.S62816</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Zheng X.X., Jiang Y.R. The effect of intravitreal bevacizumab injection as the initial treatment for Coats' disease. Graefes Arch. Clin. Exp. Ophthalmol. 2014; 252(1): 35-42. doi: 10.1007/s00417-013-2409-1</mixed-citation><mixed-citation xml:lang="en">Zheng X.X., Jiang Y.R. The effect of intravitreal bevacizumab injection as the initial treatment for Coats' disease. Graefes Arch. Clin. Exp. Ophthalmol. 2014; 252(1): 35-42. doi: 10.1007/s00417-013-2409-1</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
